GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
GRAIL, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$122.42+4.61 (+3.91%)
Close on Oct 19, 2026
- Market cap
- $5.28B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
87.6%
39M of 45M shares
Institutional holders
373
65 new, 49 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 40 sales
Net sold $110.63M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 4,161,584 | 9.60% | 13G (passive) amendment | Jun 30, 2026 |
| Baker Bros. Advisors (GP) LLC | 4,028,614 | 9.80% | 13G (passive) amendment | Mar 31, 2026 |
| BlackRock, Inc. | 3,376,085 | 7.90% | 13G (passive) amendment | Jun 30, 2026 |
| Gehani, Varun N. | 3,253,684 | 7.80% | 13G (passive) amendment | Mar 31, 2026 |
| State Street Corporation | 2,385,514 | 5.60% | 13G (passive) | Jun 30, 2026 |
| Dunn Hannah E. | 2,342,684 | 5.90% | 13G (passive) amendment | Dec 31, 2025 |
| Primecap Management Co/Ca/ | 21,801,016 | 5.08% | 13G (passive) amendment | Jun 30, 2026 |
| Felix J. Baker | 2,085,333 | 5.30% | 13G (passive) | Dec 31, 2025 |
| Crcm LLC | 1,800,651 | 5.00% | 13G (passive) amendment | Oct 6, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GRAL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Farallon Capital Management LLC | 4,161,584 | 9.32% | $284.11M | +907,900 | 1.31% |
| Baker Bros. Advisors LP | 4,028,614 | 9.02% | $275.03M | – | 1.38% |
| BlackRock, Inc. | 3,577,075 | 8.01% | $244.21M | +608,539 | 0.00% |
| State Street Corp | 2,385,514 | 5.34% | $162.86M | +493,621 | 0.00% |
| Primecap Management Co/Ca/ | 2,180,106 | 4.88% | $148.84M | +336,334 | 0.09% |
| Arbiter Partners Capital Management LLC | 2,068,594 | 4.63% | $141.22M | +1,033,997 | 37.19% |
| Sessa Capital IM, L.P. | 2,037,518 | 4.56% | $139.10M | +318,204 | 2.33% |
| Deep Track Capital, LP | 1,834,944 | 4.11% | $125.27M | +112,147 | 1.82% |
| Vanguard Capital Management LLC | 1,641,117 | 3.67% | $112.04M | +114,012 | 0.00% |
| Morgan Stanley | 1,462,163 | 3.27% | $99.82M | −170,032 | 0.01% |
| Geode Capital Management, LLC | 991,380 | 2.22% | $67.69M | +163,438 | 0.00% |
| Goldman Sachs Group Inc | 748,015 | 1.67% | $51.07M | +166,091 | 0.00% |
| Jefferies Financial Group Inc. | 724,000 | 1.62% | $49.43M | +66,500 | 0.33% |
| Bank Of America Corp /De/ | 723,437 | 1.62% | $49.39M | −190,677 | 0.00% |
| Dimensional Fund Advisors LP | 679,587 | 1.52% | $46.40M | +270,937 | 0.01% |
| Casdin Capital, LLC | 480,000 | 1.07% | $32.77M | +250,000 | 1.64% |
| Vanguard Portfolio Management LLC | 477,982 | 1.07% | $32.63M | +143,076 | 0.00% |
| Northern Trust Corp | 372,588 | 0.83% | $25.44M | +23,451 | 0.00% |
| Citigroup Inc | 371,253 | 0.83% | $25.35M | +69,117 | 0.01% |
| Kingdon Capital Management, L.L.C. | 340,000 | 0.76% | $23.21M | New | 2.38% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 373 | 39M | 87.6% | 65 / 119 | 98 / 49 | 7M | 3M |
| Q1 2026 | 366 | 35M | 78.8% | 48 / 102 | 112 / 99 | 11M | 3M |
| Q4 2025 | 425 | 30M | 67.3% | 118 / 124 | 99 / 37 | 9M | 3M |
| Q3 2025 | 348 | 25M | 56.0% | 57 / 77 | 111 / 52 | 4M | 5M |
| Q2 2025 | 344 | 26M | 59.1% | 72 / 99 | 75 / 41 | 5M | 3M |
| Q1 2025 | 315 | 24M | 53.9% | 42 / 87 | 90 / 58 | 3M | 6M |
| Q4 2024 | 333 | 27M | 59.8% | 80 / 72 | 82 / 50 | 8M | 3M |
| Q3 2024 | 311 | 22M | 49.3% | 89 / 54 | 112 / 144 | 9M | 8M |
| Q2 2024 | 371 | 22M | 48.7% | 371 / 0 | 0 / 1 | 22M | 0M |
| Q1 2024 | 2 | 0M | 0.0% | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of GRAL | Value | % of fund | As of |
|---|---|---|---|---|---|
| PRIMECAP Odyssey Aggressive Growth Fund | 1,579,791 | 3.54% | $108.31M | 1.46% | Jul 31, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 1,425,535 | 3.19% | $97.32M | 0.91% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,228,548 | 2.75% | $83.87M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,075,472 | 2.41% | $73.42M | 0.09% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 451,835 | 1.01% | $30.98M | 0.09% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 386,539 | 0.87% | $26.39M | 0.18% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 374,391 | 0.84% | $25.56M | 0.03% | Jun 30, 2026 |
| iShares Biotechnology ETF | 280,947 | 0.63% | $19.18M | 0.21% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 180,602 | 0.40% | $12.95M | 0.07% | May 31, 2026 |
| Vanguard Capital Opportunity Fund | 165,188 | 0.37% | $11.28M | 0.03% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 153,608 | 0.34% | $11.01M | 0.03% | May 31, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 144,667 | 0.32% | $9.88M | 0.09% | Jun 30, 2026 |
| Schwab U.S. Small-Cap ETF | 143,168 | 0.32% | $10.26M | 0.05% | May 31, 2026 |
| Dimensional U.S. Small Cap ETF | 138,238 | 0.31% | $9.48M | 0.06% | Jul 31, 2026 |
| U.S. Small Cap Portfolio | 135,296 | 0.30% | $9.28M | 0.05% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joshua J. Ofman | Chief Executive Officer, Director | 382,392 | 0.86% | Sep 23, 2026 |
| Robert P. Ragusa | Chief Executive Officer, Director | 518,582 | 1.16% | Apr 9, 2026 |
| Aaron Freidin | Chief Financial Officer | 249,504 | 0.56% | Sep 23, 2026 |
| Andrew John Partridge | Chief Growth Officer | 163,738 | 0.37% | Jun 5, 2026 |
| William J. Chase | Director | 42,978 | 0.10% | Jul 16, 2026 |
| Steven Mizell | Director | 42,830 | 0.10% | Jul 16, 2026 |
| Gregory L. Summe | Director | 45,672 | 0.10% | Jul 16, 2026 |
| Sarah Krevans | Director | 42,628 | 0.10% | Jun 22, 2026 |
| Illumina, Inc. | 10% owner | 3,502,126 | 7.84% | Nov 18, 2025 |
| Chun R. Ding | 10% owner | 3,332,898 | 7.46% | Jul 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Joshua J. Ofman Chief Executive Officer, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −37,752 | $94.98 | $3.59M | 382,392 |
| Joshua J. Ofman Chief Executive Officer, Director | Sep 21, 2026 | Option exercise | +26,452 | $14.00 | $370.33K | 423,723 |
| Joshua J. Ofman Chief Executive Officer, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −2,125 | $92.32 | $196.18K | 421,598 |
| Joshua J. Ofman Chief Executive Officer, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −1,454 | $93.61 | $136.11K | 420,144 |
| Joshua J. Ofman Chief Executive Officer, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −6,200 | $96.43 | $597.87K | 376,192 |
| Joshua J. Ofman Chief Executive Officer, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −10,000 | $110.00 | $1.10M | 362,271 |
| Joshua J. Ofman Chief Executive Officer, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −2,100 | $100.68 | $211.43K | 372,271 |
| Joshua J. Ofman Chief Executive Officer, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −421 | $99.85 | $42.04K | 374,371 |
| Joshua J. Ofman Chief Executive Officer, Director | Sep 21, 2026 | Sale(10b5-1 plan) | −1,400 | $97.84 | $136.98K | 374,792 |
| Aaron Freidin Chief Financial Officer | Sep 21, 2026 | Sale(10b5-1 plan) | −1,800 | $93.92 | $169.06K | 249,504 |
| Aaron Freidin Chief Financial Officer | Sep 21, 2026 | Sale(10b5-1 plan) | −521 | $95.00 | $49.50K | 248,983 |
| Aaron Freidin Chief Financial Officer | Sep 21, 2026 | Sale(10b5-1 plan) | −1,779 | $92.26 | $164.13K | 251,304 |
| Aaron Freidin Chief Financial Officer | Aug 27, 2026 | Sale(10b5-1 plan) | −7,900 | $85.01 | $671.58K | 253,083 |
| Joshua J. Ofman Chief Executive Officer, Director | Aug 27, 2026 | Sale(10b5-1 plan) | −5,000 | $85.02 | $425.10K | 397,271 |
| William J. Chase Director | Jul 15, 2026 | Award | +276 | $74.36 | $20.52K | 42,978 |
| Gregory L. Summe Director | Jul 15, 2026 | Award | +427 | $74.36 | $31.75K | 45,672 |
| Steven Mizell Director | Jul 15, 2026 | Award | +268 | $74.36 | $19.93K | 42,830 |
| Gregory L. Summe Director | Jun 18, 2026 | Award | +5,491 | $63.74 | $350.00K | 45,245 |
| William J. Chase Director | Jun 18, 2026 | Award | +5,491 | $63.74 | $350.00K | 42,702 |
| Steven Mizell Director | Jun 18, 2026 | Award | +5,491 | $63.74 | $350.00K | 42,562 |
| Sarah Krevans Director | Jun 18, 2026 | Award | +5,491 | $63.74 | $350.00K | 42,628 |
| Andrew John Partridge Chief Growth Officer | Jun 4, 2026 | Sale | −1,491 | $61.08 | $91.07K | 163,738 |
| Joshua J. Ofman Chief Executive Officer, Director | Jun 3, 2026 | Award | +3,154 | $61.13 | $192.80K | 402,271 |
| Joshua J. Ofman Chief Executive Officer, Director | Jun 1, 2026 | Award | +27,901 | $64.40 | $1.80M | 399,117 |
| Steven Mizell Director | Apr 15, 2026 | Award | +396 | $49.79 | $19.72K | 37,071 |
| Gregory L. Summe Director | Apr 15, 2026 | Award | +631 | $49.79 | $31.42K | 39,754 |
| William J. Chase Director | Apr 15, 2026 | Award | +408 | $49.79 | $20.31K | 37,211 |
| Robert P. Ragusa Chief Executive Officer, Director | Apr 8, 2026 | Sale | −123,502 | $49.92 | $6.17M | 518,582 |
| Joshua J. Ofman President, Director | Apr 8, 2026 | Sale | −61,665 | $49.92 | $3.08M | 371,216 |
| Aaron Freidin Chief Financial Officer | Apr 8, 2026 | Sale | −45,806 | $49.92 | $2.29M | 260,669 |
| Aaron Freidin Chief Financial Officer | Mar 9, 2026 | Sale | −85 | $46.74 | $3.97K | 306,475 |
| Aaron Freidin Chief Financial Officer | Mar 9, 2026 | Sale | −2,407 | $47.93 | $115.37K | 306,560 |
| Robert P. Ragusa Chief Executive Officer, Director | Mar 9, 2026 | Sale | −7,203 | $47.93 | $345.24K | 642,342 |
| Robert P. Ragusa Chief Executive Officer, Director | Mar 9, 2026 | Sale | −258 | $46.73 | $12.06K | 642,084 |
| Joshua J. Ofman President | Mar 9, 2026 | Sale | −2,836 | $47.93 | $135.93K | 432,982 |
| Joshua J. Ofman President | Mar 9, 2026 | Sale | −101 | $46.74 | $4.72K | 432,881 |
| Aaron Freidin Chief Financial Officer | Mar 5, 2026 | Sale | −655 | $53.01 | $34.72K | 308,967 |
| Robert P. Ragusa Chief Executive Officer, Director | Mar 5, 2026 | Sale | −980 | $53.01 | $51.95K | 649,545 |
| Joshua J. Ofman President | Mar 5, 2026 | Sale | −690 | $53.01 | $36.58K | 435,818 |
| Aaron Freidin Chief Financial Officer | Mar 2, 2026 | Sale | −438 | $51.86 | $22.71K | 309,622 |
| Aaron Freidin Chief Financial Officer | Mar 2, 2026 | Sale | −9,135 | $50.09 | $457.57K | 310,060 |
| Robert P. Ragusa Chief Executive Officer, Director | Mar 2, 2026 | Sale | −35,787 | $50.09 | $1.79M | 652,242 |
| Robert P. Ragusa Chief Executive Officer, Director | Mar 2, 2026 | Sale | −1,717 | $51.84 | $89.01K | 650,525 |
| Joshua J. Ofman President | Mar 2, 2026 | Sale | −779 | $51.75 | $40.31K | 452,731 |
| Joshua J. Ofman President | Mar 2, 2026 | Sale | −16,223 | $50.09 | $812.61K | 436,508 |
| Aaron Freidin Chief Financial Officer | Feb 27, 2026 | Award | +60,118 | $53.23 | $3.20M | 319,195 |
| Joshua J. Ofman President | Feb 27, 2026 | Award | +84,540 | $53.23 | $4.50M | 453,510 |
| Gregory L. Summe Director | Jan 15, 2026 | Award | +329 | $97.44 | $32.06K | 39,123 |
| Steven Mizell Director | Jan 15, 2026 | Award | +206 | $97.44 | $20.07K | 36,675 |
| William J. Chase Director | Jan 15, 2026 | Award | +213 | $97.44 | $20.75K | 36,803 |
| Aaron Freidin Chief Financial Officer | Dec 3, 2025 | Sale | −25,000 | $99.15 | $2.48M | 259,077 |
| Robert P. Ragusa Chief Executive Officer, Director | Dec 3, 2025 | Sale | −14,807 | $94.43 | $1.40M | 713,222 |
| Robert P. Ragusa Chief Executive Officer, Director | Dec 3, 2025 | Sale | −15,356 | $95.28 | $1.46M | 697,866 |
| Robert P. Ragusa Chief Executive Officer, Director | Dec 3, 2025 | Sale | −1,604 | $97.28 | $156.04K | 688,029 |
| Robert P. Ragusa Chief Executive Officer, Director | Dec 3, 2025 | Sale | −8,233 | $96.22 | $792.18K | 689,633 |
| Joshua J. Ofman President | Dec 3, 2025 | Sale | −13,000 | $100.00 | $1.30M | 368,818 |
| Aaron Freidin Chief Financial Officer | Nov 17, 2025 | Sale | −1,697 | $79.20 | $134.40K | 284,077 |
| Illumina, Inc. 10% owner | Nov 17, 2025 | Sale | −1,000,000 | $79.85 | $79.85M | 3,502,126 |
| Joshua J. Ofman President | Oct 16, 2025 | Sale(10b5-1 plan) | −6,114 | $82.01 | $501.41K | 381,818 |
| Joshua J. Ofman President | Oct 15, 2025 | Sale(10b5-1 plan) | −8,865 | $76.03 | $674.01K | 387,932 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Ofman Joshua Director, Officer | Oct 15, 2026 | 5,000 | $698.50K | Oct 15, 2026 | Restricted Stock Units |
| Partridge Andrew Officer | Oct 5, 2026 | 7,873 | $1.15M | Oct 5, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| Freidin Aaron Officer | Oct 5, 2026 | 23,619 | $3.46M | Oct 5, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| Ofman Joshua Director, Officer | Sep 21, 2026 | 71,452 | $5.77M | Sep 21, 2026 | Exercise of Stock Options |
| Ofman Joshua Director, Officer | Aug 27, 2026 | 10,000 | $795.90K | Aug 27, 2026 | Restricted Stock Units |
| Freidin Aaron Officer | Aug 27, 2026 | 12,000 | $955.08K | Aug 27, 2026 | Restricted Stock Units |
| Partridge Andrew Officer | Jun 3, 2026 | 1,705 | $104.23K | Jun 3, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| Ragusa Robert Officer, Director | Apr 6, 2026 | 133,230 | $6.89M | Apr 6, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| Ofman Joshua Officer, Director | Apr 6, 2026 | 66,522 | $3.44M | Apr 6, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| Freidin Aaron Officer | Apr 6, 2026 | 49,414 | $2.56M | Apr 3, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| Freidin Aaron Officer | Mar 5, 2026 | 3,471 | $179.80K | Mar 4, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| Ragusa Robert Officer, Director | Mar 5, 2026 | 9,285 | $480.96K | Mar 5, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| J. Ofman Joshua Officer | Mar 5, 2026 | 3,999 | $207.15K | Mar 5, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| Ragusa Robert Officer, Director | Mar 2, 2026 | 40,641 | $2.16M | Mar 2, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |
| Freidin Aaron Officer | Mar 2, 2026 | 10,374 | $552.21K | Mar 2, 2026 | Shares acquired upon vesting of restricted stock units awarded under Issuer's equity incentive plans |